Tecartus 71287-0220-02
Generic: Brexucabtagene Autoleucel
- Manufacturer
- Kite Pharma, Inc.
- Dosage Form
- Suspension
- Route
- Intravenous
- Product Type
- Cellular Therapy
- Marketing Start
- October 1, 2021
- Listing Expires
- December 31, 2027
- Application
- BLA125703
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brexucabtagene Autoleucel | 1000000 1/68mL |
Selected Package
71287-0220-02Selected1 BAG in 1 PACKAGE (71287-220-02) / 68 mL in 1 BAG (71287-220-01)